INTERNATIONAL PATENT: LANTERN PHARMA INC. FILES APPLICATION FOR "TREATING TRIPLE NEGATIVE BREAST CANCER (TNBC) WITH COMBINATIONS OF IMMUNOTHERAPY AND ACYLFULVENES"

GENEVA, Feb. 4 -- LANTERN PHARMA INC. (1920 McKinney Ave. 7th FloorDallas, TX 75201) filed a patent application (PCT/US2025/038577) for "TREATING TRIPLE NEGATIVE BREAST CANCER (TNBC) WITH COMBINATIONS OF IMMUNOTHERAPY AND ACYLFULVENES" on Jul 22, 2025. With publication no. WO/2026/024670, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BHATIA, Kishor (1920 McKinney Ave. 7th FloorDallas, TX 75201), KULKARNI, Aditya (1920 McKinney Ave. 7th FloorDallas, TX 75201), ZHOU, Jianli (1920 McKinney Ave. 7th FloorDallas, TX 75201) ...